Peyrin-Biroulet L, Ghosh S, Lee SD, Lee WJ, et al. Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Aliment Pharmacol Ther 2023;57:496-508.
PMID: 36266762